| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Volume 16(2); 2020 > Article
Korean J Clin Oncol. 2020;16(2): 145-147.         doi: https://doi.org/10.14216/kjco.20023
Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node
Jung Bum Choi1 , Dong-il Kim2 , Hyun-june Paik2 , Seung Joo Lee2 , Chang Shin Jung2 , Seok Kyung Kang2 , Youn Joo Jung2 , Hyun Yul Kim3
1Department of Surgery, Pusan National University Hospital, Busan, Korea
2Department of Surgery, Pusan National University Yangsan Hospital,Yangsan, Korea
3Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea
Corresponding Author: Dong-il Kim ,Tel: +82-55-360-2124, Fax: +82-55-360-2154, Email: led117@naver.com
Received: June 30, 2020;  Accepted: October 26, 2020.
Share :  
Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.
Keywords: Papillary thyroid carcinoma | Thyrotropin | Active surveillance | Locoregional neoplasm recurrence | Case report
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 100-717, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@paran.com

Copyright© Korean Society of Surgical Oncology. All rights reserved.                powerd by m2community
About |  Browse Articles |  Current Issue |  For Authors and Reviewers